• DFO: A Decision Framework for Fingerprint Assays

  2026-09-20

  DFO, or 9H-1,8-Diazafluoren-9-one, is more than a fluorescent fingerprint reagent: its value depends on substrate, chemistry, imaging, and controls. This evidence-focused guide explains how to design defensible latent print workflows and interpret assay results without overextending the chemistry.

• Recombinant Mouse Macrophage Colony Stimulating Factor

  2026-09-19

  Build more reproducible mouse macrophage, fibrosis, osteoclast, and tumor-cell assays with a defined, tag-free M-CSF input. This guide connects practical culture controls to the IGF2BP1-THBS1-TLR4 findings in pulmonary fibrosis research while separating validated evidence from workflow recommendations.

• Mdivi-1 for Reliable Mitochondrial Assays

  2026-09-18

  This scenario-driven guide explains how Mdivi-1 (SKU A4472), a selective DRP1 inhibitor, can strengthen mitochondrial dynamics, apoptosis, and cell-viability workflows. It covers assay design, DMSO handling, data interpretation, and practical product-selection criteria using supplier information and peer-reviewed evidence.

• Mdivi-1 for DRP1-Linked Apoptosis Assays

  2026-09-18

  Mdivi-1 is a cell-permeable selective DRP1 inhibitor for connecting mitochondrial fission with cytochrome c release, annexin V positivity, and tissue injury. This practical guide translates cell, animal, and multi-omics findings into assay workflows, controls, and troubleshooting decisions.

• 5-Methyl-CTP for Reliable mRNA Assays

  2026-09-17

  Learn how 5-Methyl-CTP (SKU B7967) can support more consistent mRNA-based viability, proliferation, and cytotoxicity workflows through controlled transcript synthesis and practical reagent handling. This scenario-driven guide separates product-supported facts from assay recommendations and highlights limitations when translating mRNA vaccine evidence to cell-based experiments.

• α-KG–LKB1–AMPK Restores HPDLSCs in Periodontitis

  2026-09-17

  This Cellular Signalling study identifies an α-ketoglutarate–LKB1–AMPK axis that restores mitochondrial homeostasis and limits inflammation-induced senescence in human periodontal ligament stem cells. By combining LPS-treated cell experiments with a ligature-induced rat model, the work connects mitochondrial recovery to improved osteogenic capacity and periodontal regeneration.

• Concanavalin A Targets Conserved Coronavirus Spike Glycans

  2026-09-16

  Guo et al. show that the plant lectin concanavalin A inhibits coronavirus entry by binding two conserved high-mannose N-glycosylation sites near the S2′ cleavage region and blocking spike activation. The study combines membrane-fusion, pseudoviral, authentic-virus, biochemical, and animal models to define a glycan-focused antiviral mechanism that complements, rather than replaces, functional entry assays.

• Coelenterazine Workflows for ROS Reporter Assays

  2026-09-16

  Coelenterazine connects luciferase reporting with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide shows how to build solvent-controlled reporter assays, adapt brain–kidney signaling logic, and extend the readout to BRET, HTS, and cancer-associated reactive oxygen species imaging.

• Pregnenolone Carbonitrile in Gut–Liver Research

  2026-09-15

  Pregnenolone Carbonitrile is more than a rodent PXR tool for CYP3A induction. This article explains how PCN can be used to dissect gut–liver signaling, microbiota dependence, YAP activation, and assay design in sepsis-related liver injury models.

• ZIF8 Nanotheranostics for Triple-Negative Breast Cancer

  2026-09-15

  Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted, pH-responsive ZIF8 platform that combines ciprofloxacin delivery, ultrasound imaging, sonodynamic therapy, chemotherapy, and immune activation for triple-negative breast cancer. The study links ultrasound-triggered reactive oxygen species generation with immunogenic cell death and increased cytotoxic T-cell infiltration, while also demonstrating tumor imaging capability.

• GPC3-HSP70 mRNA Nanovaccine for HCC Immunotherapy

  2026-09-14

  The reference study develops a GPC3-targeted mRNA nanovaccine that combines tandem CTL epitopes, HSP70-mediated immune stimulation, and SP94-guided tumor delivery. In preclinical experiments, pairing the vaccine with anti-PD-L1 therapy strengthened antigen-specific T-cell responses and produced greater antitumor activity than either strategy alone.

• Clathrin-Mediated Entry of Type III GCRV

  2026-09-14

  Wang et al. used complementary inhibitor profiling, transmission electron microscopy, and quantitative PCR to define how genotype III grass carp reovirus enters CIK cells. Their results identify a dynamin-dependent, acidification-sensitive clathrin-mediated pathway and show that IPA-3 did not measurably block infection under the tested conditions, making it a useful negative pharmacological comparator rather than an antiviral lead in this study.

• Prochlorperazine: From Stroke Mimic to Assay Design

  2026-09-13

  Prochlorperazine is a dopamine D2 receptor antagonist with applications spanning antiemetic therapy, melanoma research, and mechanistic cell studies. This article develops a clinically informed framework for interpreting neurological phenotypes, selecting assay windows, and separating translational evidence from experimental hypothesis.

• Gly-Gly-Phe-Gly: A Linker for Assay Design

  2026-09-12

  Gly-Gly-Phe-Gly, or the GGFG peptide, can be treated as a controlled variable in bioconjugation assays rather than merely a passive spacer. This article connects linker chemistry with pharmacodynamic assay logic, biomarker interpretation, and practical handling decisions.

• Anti Reverse Cap Analog: mRNA Design Framework

  2026-09-11

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, improves the interpretability of synthetic mRNA experiments by favoring productive cap orientation. This guide connects cap chemistry with translation initiation, formulation decisions, and lessons from targeted mRNA delivery research.

8077 records 1/539 page Next 12345 下5页 Last page